Differentiation of murine B cells induced by chondroitin sulfate B

Cellular Immunology
Ritsuko YoshiharaEiichi Gohda

Abstract

A two-step culture system was used to investigate the role of chondroitin sulfate (CS) B, which is mitogenic to B cells, in differentiation of B cells. Mouse spleen B cells were incubated for 3 days with CSB in the presence of interleukin (IL)-4 and IL-5. After washing, the cells were replated at 10(5) viable cells/well and recultured without CSB in the presence of IL-4 and IL-5. CSB dose-dependently increased IgM production, the greatest enhancement being 450%. Dextran sulfate had a similar effect, whereas other glycosaminoglycans, CSA, CSC, heparin and hyaluronic acid, were marginally effective. Treatment of B cells with CSB resulted in increases in the number of IgM-secreting cells and numbers of CD138-positive cells and CD45R/B220-negative cells. CSB-induced IgM production was inhibited by the protein kinase C (PKC) inhibitor GF109203X but not by the phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin. These results demonstrated that CSB promoted differentiation of B cells in the presence of IL-4 and IL-5 and suggested that PKC but not PI3K is crucial for CSB-induced IgM production.

References

Jan 1, 1990·Rheumatology International·D R Mitrovic, N Darmon
Nov 1, 1989·Cell Regulation·R D SandersonM Bernfield
Feb 25, 1983·Journal of Immunological Methods·J D Sedgwick, P G Holt
Sep 1, 1995·Clinical Immunology and Immunopathology·H ShinI Maruyama
Aug 9, 1996·Science·M LeitgesA Tarakhovsky
Oct 17, 1998·The Journal of Biological Chemistry·S F PencR L Gallo
Nov 29, 2001·Nature Immunology·K L Calame
Apr 25, 2002·Molecular Microbiology·Franco D MenozziCamille Locht
Sep 6, 2002·Glycobiology·Janet M Trowbridge, Richard L Gallo
Sep 18, 2002·The Journal of Experimental Medicine·Elizabeth ClaytonMartin Turner
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Julia Y Wang, Michael H Roehrl
Oct 22, 2003·Current Opinion in Structural Biology·Kazuyuki SugaharaHiroshi Kitagawa
Jan 6, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kristen R Taylor, Richard L Gallo
Aug 10, 2006·Immunology·Keisuke Horikawa, Kiyoshi Takatsu
Feb 3, 2007·European Journal of Immunology·Nataly Manjarrez-OrduñoLeopoldo Santos-Argumedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.